Todd Young
Director of Finance/CFO bij ELANCO ANIMAL HEALTH INCORPORATED
Vermogen: 4 M $ op 31-03-2024
Actieve functies van Todd Young
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ELANCO ANIMAL HEALTH INCORPORATED | Director of Finance/CFO | 14-12-2018 | - |
Loopbaan van Todd Young
Eerdere bekende functies van Todd Young
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| ACADIA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 22-08-2016 | 31-10-2018 |
| Director of Finance/CFO | 22-08-2016 | 31-10-2018 | |
| Sidley & Austin | Corporate Officer/Principal | - | - |
| BAXALTA INC | Corporate Officer/Principal | - | - |
| Treasurer | - | - | |
| BAXTER INTERNATIONAL INC. | Treasurer | 01-01-2001 | - |
Opleiding van Todd Young
| Grinnell College | Undergraduate Degree |
| The University of Michigan Law School | Graduate Degree |
Statistieken
Internationaal
| Verenigde Staten | 8 |
Operationeel
| Treasurer | 2 |
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 2 |
Sectoraal
| Health Technology | 5 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 3 |
|---|---|
| BAXTER INTERNATIONAL INC. | Health Technology |
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| ELANCO ANIMAL HEALTH INCORPORATED | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
| Sidley & Austin | Commercial Services |
- Beurs
- Insiders
- Todd Young
- Ervaring
